Rathbones Group’s MaxCyte MXCT Stock Holding History

Rathbones Group’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$247K	Sell	200,841 -22,537	-10%	-$22.5K	﹤0.01%	578
2026 Q1	$157K	Sell	223,378 -3,469	-2%	-$3.24K	﹤0.01%	599
2025 Q4	$352K	Sell	226,847 -6,815	-3%	-$10.9K	﹤0.01%	498
2025 Q3	$369K	Sell	233,662 -3,583	-2%	-$6.23K	﹤0.01%	488
2025 Q2	$493K	Sell	237,245 -7,396	-3%	-$17.9K	﹤0.01%	438
2025 Q1	$661K	Sell	244,641 -8,466	-3%	-$33.4K	﹤0.01%	373
2024 Q4	$1.03M	Hold	253,107	–	–	0.01%	334
2024 Q3	$995K	Sell	253,107 -9,634	-4%	-$40.6K	0.01%	332
2024 Q2	$1.07M	Sell	262,741 -20,135	-7%	-$86.6K	0.01%	323
2024 Q1	$1.22M	Sell	282,876 -18,112	-6%	-$85K	0.01%	304
2023 Q4	$1.35M	Sell	300,988 -2,730	-0.9%	-$10.6K	0.01%	289
2023 Q3	$945K	Sell	303,718 -37,603	-11%	-$151K	0.01%	320
2023 Q2	$1.52M	Sell	341,321 -21,263	-6%	-$97.7K	0.01%	221
2023 Q1	$1.75M	Sell	362,584 -5,004	-1%	-$24.6K	0.02%	217
2022 Q4	$1.93M	Sell	367,588 -19,014	-5%	-$117K	0.02%	202
2022 Q3	$2.5M	Sell	386,602 -10,780	-3%	-$60.1K	0.03%	189
2022 Q2	$1.83M	Sell	397,382 -10,785	-3%	-$53.1K	0.02%	214
2022 Q1	$2.89M	Sell	408,167 -19,854	-5%	-$136K	0.03%	191
2021 Q4	$4.38M	Sell	428,021 -19,267	-4%	-$207K	0.04%	166
2021 Q3	$5.43M	Buy	+447,288	New	+$6.74M	0.06%	153

Other funds holding MXCT

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $128M AUM

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Rathbones Group's MXCT Position: Q2 2026 in Review

Rathbones Group reduced its MaxCyte (MXCT) stake by 10% in Q2 2026, selling an estimated $22.5K and leaving 200,841 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #578.

Rathbones Group first reported a position in MXCT in Q3 2021 and has held it in 20 quarters since. The position peaked at $5.43M in Q3 2021. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

Rathbones Group held 200,841 shares of MaxCyte worth $247K as of Q2 2026.
Rathbones Group sold 22,537 MaxCyte shares in Q2 2026, an estimated $22.5K.
MaxCyte made up ﹤0.01% of Rathbones Group's portfolio in Q2 2026, its #578 holding.
Rathbones Group first reported a position in MaxCyte in Q3 2021 and has held it in 20 quarters since.
Rathbones Group's MaxCyte position peaked at $5.43M in Q3 2021.
123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Rathbones Group's 13F filing for Q2 2026, filed 23 Jul 2026.